Bigul

VENUS REMEDIES LTD. - 526953 - Compliance Certificate Under Regulation 7(3) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 For The Period Ended On 31.03.2022.

compliance certificate under regulation 7(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 for the period ended on 31.03.2022.
13-04-2022
Bigul

VENUS REMEDIES LTD. - 526953 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

In compliance with Regulation 74(5) of Securities and Exchange Board of India (Depositories and Participants)Regulation, 2018, we enclose herewith Confirmation Certificate received from our Registrar & Transfer Agent, M/s. Link Intime India Pvt Ltd. for the quarter ended 31.03.2022
13-04-2022
Bigul

VENUS REMEDIES LTD. - 526953 - Closure of Trading Window

this is to inform that trading window for dealing in equity shares of the Company shall remain closed for all Designated Persons of the Company, as defined under the said Regulations, from April 1, 2022 till 48 hours from the declaration of the Audited Financial Results for the quarter and year ending on March 31, 2022
31-03-2022
Bigul

VENUS REMEDIES LTD. - 526953 - Announcement under Regulation 30 (LODR)-Press Release / Media Release

Press Release- Venus Remedies wins WHO GDP certification for quality services across entire supply chain. Kindly find enclosed herewith is a press release being issued by the Company on the captioned subject regarding WHO-GDP certification accredited to the Company.
09-03-2022
Bigul

VENUS REMEDIES LTD. - 526953 - Announcement under Regulation 30 (LODR)-Newspaper Publication

Please find enclosed herewith newspaper publication of notice for issue of duplicate shares in lieu of loss of shares
18-02-2022
Bigul

VENUS REMEDIES LTD. - 526953 - Announcement under Regulation 30 (LODR)-Newspaper Publication

Newspaper publication of Financial Results for the quarter ended on 31.12.2021.
01-02-2022
Bigul

VENUS REMEDIES LTD. - 526953 - Financial Results As On 31.12.2021

Financial Results as on 31.12.2021
31-01-2022
Bigul

VENUS REMEDIES LTD. - 526953 - Board Meeting Outcome for Outcome Of Board Meeting

This has reference to the meeting of Board of Directors held on 31st January 2022 inter alia considered and approved the Unaudited Financial Results for the quarter and nine months ended on 31st December 2021 along with Limited Review report.
31-01-2022
Bigul

VENUS REMEDIES LTD. - 526953 - Announcement under Regulation 30 (LODR)-Press Release / Media Release

Press Release- VENUS REMEDIES IS NOW GREAT PLACE TO Work-Certified(tm)!
21-01-2022
Next Page
Close

Let's Open Free Demat Account